home / stock / poai / poai news

POAI News and Press, Predictive Oncology Inc. From 05/15/23

Stock Information
Company Name: Predictive Oncology Inc.
Stock Symbol: POAI
Market: NASDAQ
Website: predictive-oncology.com
Menu
POAI POAI Quote POAI Short POAI News POAI Articles POAI Message Board
Get POAI Alerts

News, Short Squeeze, Breakout and More Instantly...
POAI - Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update

EAGAN, Minn., May 15, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLI laboratory and GMP facility, to accelerate onco...
POAI - Notable earnings after Monday's close

2023-05-14 17:35:54 ET Major earnings expected after the bell on Monday include: Danaos Corporation ( DAC ) Canoo ( GOEV ) Arrival ( ARVL ) Cara Therapeutics ( CARA ) Fortuna Silver Mines ( FSM ) For further details see: Notable earnings a...

POAI - Immuron, ANI Pharmaceuticals top healthcare gainers; Catalent, Aptorum among losers

2023-05-08 10:03:22 ET Gainers: Immuron ( IMRN ) +49% . ANI Pharmaceuticals ( ANIP ) +17% . MiNK Therapeutics ( INKT ) +13% . Evaxion Biotech ( EVAX ) +8% . Predictive Oncology ( POAI ) +8% . Losers: Catalent ( CTLT ) ...

POAI - Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023

EAGAN, Minn., May 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) l...
POAI - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Appoints Seasoned Veteran as New Board Member

Predictive Oncology (NASDAQ: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, a...

POAI - Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors

EAGAN, Minn., May 02, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) l...

POAI - ML and LGMK among mid-day movers

2023-04-25 13:30:38 ET Gainers: CXApp ( CXAI ) +82% . Petros Pharmaceuticals ( PTPI ) +49% . LogicMark ( LGMK ) +28% . Apollomics ( APLM ) +23% . The Aaron's Company ( AAN ) +18% . Baudax Bio ( BXRX ) +18% . Predi...
POAI - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Reverse Stock Split Approved, Effective April 24

Predictive Oncology (NASDAQ: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, has an...

POAI - Predictive Oncology announces 1-for-20 reverse stock split

2023-04-20 17:24:19 ET Predictive Oncology ( NASDAQ: POAI ) on Thursday said it would effect a 1-for-20 reverse stock split. The stock split will become effective on April 24. "The reverse stock split is primarily intended to bring the Company into compliance with the mini...

POAI - Predictive Oncology Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023 EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock s...
Previous 10 Next 10